Clinical Trials Browser

Phase 1 × NIH × Anemia, Refractory × Clear all

NCT00104962 2014-06-11

Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes

Phase 1 Completed

Classical hematology

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts

NCT00005845 2013-12-16

Tipifarnib in Treating Patients With Myelodysplastic Syndromes

Phase 1 Completed

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

NCT00012376 2013-01-09

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

Phase 1 Completed

Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, Blast Crisis, Hemoglobinuria, Paroxysmal, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic